<p>➀ Researchers from the University of Queensland are developing novel nanoparticles to enhance the effectiveness of immunotherapies for treating triple-negative breast cancer (TNBC); </p><p>➁ TNBC is an aggressive form of breast cancer with high mortality rates; </p><p>➂ The nanoparticles are designed to boost the immune response of TNBC patients to treatments, potentially leading to improved efficacy of immunotherapy.</p>